Literature DB >> 8874501

Partial characterization of a Sendai virus replication promoter and the rule of six.

T Pelet1, C Delenda, O Gubbay, D Garcin, D Kolakofsky.   

Abstract

We have used a cDNA copy of a natural, internally deleted, Sendai virus defective interfering genome to study the effect of insertions and deletions (which maintain the hexamer genome length) on the ability of viral genomes to be amplified in a transfected cell system. The insertion of 18 nt at nt72 (In the 5' untranslated region of the N gene, just downstream of the le+ region) was found to be lethal, whereas similar insertions further from the genome ends were well tolerated. Curiously, the insertion of 6 nt on either side of the le+/N junction (at nt47 and nt87) was well tolerated, but the insertion of 12 nt at either site, or of 6 nt at both sites, largely ablated genome amplification. These results suggest that an element of this replication promoter is located downstream of nt87, in the 5' untranslated region of the first gene. Remarkably, the addition of 6 nt by the insertion of 2, 3, or 4 nt at nt47 plus the insertion of 4, 3, or 2 nt, respectively, at nt87 was poorly tolerated, presumably because the hexamer phase of the intervening sequence was altered with respect to the N subunits of the template. These results suggest that the rule of six operates, at least in part, at the level of the initiation of antigenome synthesis.

Entities:  

Mesh:

Year:  1996        PMID: 8874501     DOI: 10.1006/viro.1996.0547

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

1.  Dissection of individual functions of the Sendai virus phosphoprotein in transcription.

Authors:  M C Bowman; S Smallwood; S A Moyer
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  "Rule of six": how does the Sendai virus RNA polymerase keep count?

Authors:  D Vulliémoz; L Roux
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Competition between the Sendai virus N mRNA start site and the genome 3'-end promoter for viral RNA polymerase.

Authors:  Philippe Le Mercier; Dominique Garcin; Eduardo Garcia; Daniel Kolakofsky
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Chemical modification of nucleotide bases and mRNA editing depend on hexamer or nucleoprotein phase in Sendai virus nucleocapsids.

Authors:  Frédéric Iseni; Florence Baudin; Dominique Garcin; Jean-Baptiste Marq; Rob W H Ruigrok; Daniel Kolakofsky
Journal:  RNA       Date:  2002-08       Impact factor: 4.942

5.  Ambisense gene expression from recombinant rabies virus: random packaging of positive- and negative-strand ribonucleoprotein complexes into rabies virions.

Authors:  S Finke; K K Conzelmann
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response.

Authors:  D Garcin; J Curran; M Itoh; D Kolakofsky
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  The various Sendai virus C proteins are not functionally equivalent and exert both positive and negative effects on viral RNA accumulation during the course of infection.

Authors:  P Latorre; T Cadd; M Itoh; J Curran; D Kolakofsky
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication.

Authors:  C Tapparel; D Maurice; L Roux
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins.

Authors:  C Tapparel; S Hausmann; T Pelet; J Curran; D Kolakofsky; L Roux
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 10.  Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.

Authors:  D Kolakofsky; T Pelet; D Garcin; S Hausmann; J Curran; L Roux
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.